Clinically unrecognized Q-wave mycocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy

被引：18
作者：
Aguilar, D
Goldhaber, SZ
Gans, DJ
Levey, AS
Porush, JG
Lewis, JB
Rouleau, JL
Berl, T
Lewis, EJ
Pfeffer, MA
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[2] Bristol Myers Squibb Pharmaceut Res Inst, Pennington, NJ USA
[3] Tufts Univ New England Med Ctr, Boston, MA USA
[4] Brookdale Univ Hosp, Brooklyn, NY USA
[5] Ctr Med, Brooklyn, NY USA
[6] Vanderbilt Univ, Coll Med, Nashville, TN USA
[7] Univ Montreal, Montreal, PQ, Canada
[8] Univ Colorado, Sch Med, Denver, CO 80202 USA
[9] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[10] Univ Texas, Hlth Sci Ctr, Div Cardiol, Houston, TX USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 03期
关键词：
D O I：
10.1016/j.amjcard.2004.04.028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
During the Irbesartan Diabetic Nephropathy Trial, 1,387 participants with type 2 diabetes mellitus, hypertension, and nephropathy underwent serial electrocardiograms for the identification of Q-wave myocardial infarction (MI). During a mean follow-up of 2.5 years, 14 of 99 first nonfatal MIs in this group were clinically unrecognized, accounting for 14% of all first nonfatal MIs. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码：337 / 339
页数：3
相关论文
共 17 条
  • [1] Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy[J]. Berl, T;Hunsicker, LG;Lewis, JB;Pfeffer, MA;Porush, JG;Rouleau, JL;Drury, PL;Esmatjes, E;Hricik, D;Parikh, CR;Raz, I;Vanhille, P;Wiegmann, TB;Wolfe, BM;Locatelli, F;Goldhaber, SZ;Lewis, EJ. ANNALS OF INTERNAL MEDICINE, 2003(07)
  • [2] Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (The ARIC study)[J]. Boland, LL;Folsom, AR;Sorlie, PD;Taylor, HA;Rosamond, WD;Chambless, LE;Cooper, LS. AMERICAN JOURNAL OF CARDIOLOGY, 2002(09)
  • [3] Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with, diabetes mellitus and no known coronary artery disease[J]. De Lorenzo, A;Lima, RSL;Siqueira, AG;Pantoja, MR. AMERICAN JOURNAL OF CARDIOLOGY, 2002(08)
  • [4] Prevalence, determinants, and misclassification of myocardial infarction in the elderly[J]. deBruyne, MC;Mosterd, A;Hoes, AW;Kors, JA;Kruijssen, DACM;vanBemmel, JH;Hofman, A;Grobbee, DE. EPIDEMIOLOGY, 1997(05)
  • [5] Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals[J]. Gerstein, HC;Mann, JFE;Yi, QL;Zinman, B;Dinneen, SF;Hoogwerf, B;Hallé, JP;Young, J;Rashkow, A;Joyce, C;Nawaz, S;Yusuf, S. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001(04)
  • [6] GRIMM RH, 1987, CIRCULATION, V75, P6
  • [7] Incidence and prevalence of recognised and unrecognised myocardial infarction in women - The Reykjavik Study[J]. Jonsdottir, LS;Sigfusson, N;Sigvaldason, H;Thorgeirsson, G. EUROPEAN HEART JOURNAL, 1998(07)
  • [8] INCIDENCE AND PROGNOSIS OF UNRECOGNIZED MYOCARDIAL-INFARCTION - AN UPDATE ON THE FRAMINGHAM-STUDY[J]. KANNEL, WB;ABBOTT, RD. NEW ENGLAND JOURNAL OF MEDICINE, 1984(18)
  • [9] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J]. Lewis, EJ;Hunsicker, LG;Clarke, WR;Berl, T;Pohl, MA;Lewis, JB;Ritz, E;Atkins, RC;Rohde, R;Raz, I. NEW ENGLAND JOURNAL OF MEDICINE, 2001(12)
  • [10] UNRECOGNIZED MYOCARDIAL-INFARCTION - 5-YEAR INCIDENCE, MORTALITY, AND RISK-FACTORS[J]. MEDALIE, JH;GOLDBOURT, U. ANNALS OF INTERNAL MEDICINE, 1976(05)
12